US Patent Issued to SynDevRx on Sept. 23 for "Biomarkers of METAP2 inhibitors and applications thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,846, issued on Sept. 23, was assigned to SynDevRx Inc. (Cambridge, Mass.).

"Biomarkers of METAP2 inhibitors and applications thereof" was invented by Peter Cornelius (Framingham, Mass.) and James Shanahan (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to modified or polymer conjugated MetAP2 inhibitors. The present disclosure also relates to methods of treating, or ameliorating at least one symptom of, metabolic dysfunction associated with a treatment in a subject having cancer. The present disclosure also relates to methods of treating, or ameliorating at least one symptom of, cancer comprising admi...